Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Effectiveness of metformin on weight loss in non-diabetic individuals with obesity.

Seifarth C, Schehler B, Schneider HJ.

Exp Clin Endocrinol Diabetes. 2013 Jan;121(1):27-31. doi: 10.1055/s-0032-1327734.

PMID:
23147210
2.

Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.

Brunani A, Caumo A, Graci S, Castagna G, Viberti G, Liuzzi A.

Diabetes Obes Metab. 2008 Jun;10(6):460-7.

PMID:
17394563
3.

Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin.

Glueck CJ, Moreira A, Goldenberg N, Sieve L, Wang P.

Hum Reprod. 2003 Aug;18(8):1618-25.

PMID:
12871871
6.

Pioglitazone metabolic effect in metformin-intolerant obese patients treated with sibutramine.

Derosa G, Mereu R, Salvadeo SA, D'Angelo A, Ciccarelli L, Piccinni MN, Ferrari I, Gravina A, Maffioli P, Cicero AF.

Intern Med. 2009;48(5):265-71.

7.

Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.

Derosa G, Cicero AF, Gaddi AV, Ciccarelli L, Piccinni MN, Salvadeo S, Pricolo F, Fogari E, Ghelfi M, Ferrari I, Fogari R.

Clin Ther. 2005 Sep;27(9):1383-91.

PMID:
16291411
8.

The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome.

Yilmaz M, Biri A, Karakoç A, Törüner F, Bingöl B, Cakir N, Tiras B, Ayvaz G, Arslan M.

J Endocrinol Invest. 2005 Dec;28(11):1003-8.

PMID:
16483179
9.

Therapeutic approach in insulin resistance with acanthosis nigricans.

Tankova T, Koev D, Dakovska L, Kirilov G.

Int J Clin Pract. 2002 Oct;56(8):578-81.

PMID:
12425366
10.

Evaluation of the safety and efficacy of sibutramine, orlistat and metformin in the treatment of obesity.

Gokcel A, Gumurdulu Y, Karakose H, Melek Ertorer E, Tanaci N, BascilTutuncu N, Guvener N.

Diabetes Obes Metab. 2002 Jan;4(1):49-55.

PMID:
11874442
11.

Metformin in combination with structured lifestyle intervention improved body mass index in obese adolescents, but did not improve insulin resistance.

Clarson CL, Mahmud FH, Baker JE, Clark HE, McKay WM, Schauteet VD, Hill DJ.

Endocrine. 2009 Aug;36(1):141-6. doi: 10.1007/s12020-009-9196-9.

PMID:
19387874
12.

Insulin sensitizing drugs for weight loss in women of reproductive age who are overweight or obese: systematic review and meta-analysis.

Nieuwenhuis-Ruifrok AE, Kuchenbecker WK, Hoek A, Middleton P, Norman RJ.

Hum Reprod Update. 2009 Jan-Feb;15(1):57-68. doi: 10.1093/humupd/dmn043. Review.

PMID:
18927072
13.

Metformin in the treatment of obesity in subjects with normal glucose tolerance.

Tankova T, Dakovska L, Kirilov G, Koev D.

Rom J Intern Med. 2003;41(3):269-75.

PMID:
15526510
14.
15.

The effect of orlistat-induced weight loss, without concomitant hypocaloric diet, on cardiovascular risk factors and insulin sensitivity in young obese Chinese subjects with or without type 2 diabetes.

Tong PC, Lee ZS, Sea MM, Chow CC, Ko GT, Chan WB, So WY, Ma RC, Ozaki R, Woo J, Cockram CS, Chan JC.

Arch Intern Med. 2002 Nov 25;162(21):2428-35.

PMID:
12437401
16.

Preliminary report of hypoglycemic response in obese metabolic syndrome males treated with metformin after weight loss intervention.

Tesanović S, Radman M, Tesanović D, Erzen DJ, Hozo I.

Coll Antropol. 2013 Jun;37(2):367-71.

PMID:
23940976
17.

Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial.

Derosa G, Salvadeo SA, D'Angelo A, Ferrari I, Mereu R, Palumbo I, Maffioli P, Randazzo S, Cicero AF.

Curr Med Res Opin. 2009 Mar;25(3):607-15. doi: 10.1185/03007990802711024 .

PMID:
19232035
18.

Comparison of the effects of sibutramine versus sibutramine plus metformin in obese women.

Sari R, Eray E, Ozdem S, Akbas H, Coban E.

Clin Exp Med. 2010 Sep;10(3):179-84. doi: 10.1007/s10238-009-0080-y.

PMID:
19937362
19.
20.

Role of metformin for weight management in patients without type 2 diabetes.

Desilets AR, Dhakal-Karki S, Dunican KC.

Ann Pharmacother. 2008 Jun;42(6):817-26. doi: 10.1345/aph.1K656. Review.

PMID:
18477733

Supplemental Content

Support Center